Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 10 (1), 1767

Left Atrial Dysfunction in Sickle Cell Anemia Is Associated With Diffuse Myocardial Fibrosis, Increased Right Ventricular Pressure and Reduced Exercise Capacity

Affiliations

Left Atrial Dysfunction in Sickle Cell Anemia Is Associated With Diffuse Myocardial Fibrosis, Increased Right Ventricular Pressure and Reduced Exercise Capacity

Tarek Alsaied et al. Sci Rep.

Erratum in

Abstract

Increased extracellular volume (ECV) by CMR is a marker of interstitial myocardial fibrosis and is associated with diastolic dysfunction in sickle cell anemia (SCA). Left atrial (LA) dysfunction and stiffness contribute to the development of diastolic heart failure in other settings. We aimed to evaluate LA function and stiffness associations with ECV, tricuspid regurgitation jet velocity (TRV) and exercise abnormalities in SCA. In a prospective study, individuals with SCA underwent CMR, echocardiography and exercise test. ECV was measured using MOLLI sequence. Atrial strain was studied in the 4- and 2-chamber views. LA stiffness was calculated as the ratio of echocardiographic E/e'-to-LA reservoir strain. Twenty-four participants with SCA were included (median age 20 years). ECV was increased in participant with SCA compared to our lab normal values (mean 0.44 ± 0.08 vs 0.26 ± 0.02, P < 0.0001). Six (25%) had LA LGE. ECV positively correlated with LA stiffness (r = 0.45, p = 0.04). There was a negative correlation between LA stiffness and %predicted VO2 (r = -0.50, p = 0.04). LA stiffness was moderately associated with increased TRV (r = 0.55, p < 0.005). LA stiffness is associated with ECV, exercise impairment and increased TRV. This study sheds insights on the interaction between LA function, RV hypertension, and myocardial fibrosis in SCA.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Atrial strain and strain rate by echocardiogram. (A) represent atrial strain curves measured over the cardiac cycle. The white curve represents average atrial strain curve. (B) represents atrial strain rate curve.
Figure 2
Figure 2
Left atrial late gadolinium enhancement in a patient with SCA in four chamber and three chamber views (blue arrows).
Figure 3
Figure 3
Left ventricular extracellular volume (ECV) negatively associated with atrial ejection fraction (A), positive strain rate (B) and atrial reservoir strain (C).
Figure 4
Figure 4
Left atrial stiffness negatively associated with percent predicted VO2 (A) and positively associated with VE/VCO2 slope at maximum exercise.
Figure 5
Figure 5
Left atrial stiffness correlates positively with tricuspid regurgitation velocity.
Figure 6
Figure 6
Summary of cardiac involvement in sickle cell anemia.

Similar articles

See all similar articles

References

    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38:S512–521. doi: 10.1016/j.amepre.2009.12.022. - DOI - PubMed
    1. Fitzhugh CD, et al. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. American journal of hematology. 2010;85:36–40. doi: 10.1002/ajh.21569. - DOI - PMC - PubMed
    1. Bakeer Nihal, James Jeanne, Roy Swarnava, Wansapura Janaka, Shanmukhappa Shiva Kumar, Lorenz John N., Osinska Hanna, Backer Kurt, Huby Anne-Cecile, Shrestha Archana, Niss Omar, Fleck Robert, Quinn Charles T., Taylor Michael D., Purevjav Enkhsaikhan, Aronow Bruce J., Towbin Jeffrey A., Malik Punam. Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology. Proceedings of the National Academy of Sciences. 2016;113(35):E5182–E5191. doi: 10.1073/pnas.1600311113. - DOI - PMC - PubMed
    1. Sachdev V, et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol. 2007;49:472–479. doi: 10.1016/j.jacc.2006.09.038. - DOI - PMC - PubMed
    1. Machado RF, et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA. 2006;296:310–318. doi: 10.1001/jama.296.3.310. - DOI - PubMed
Feedback